Cryoablation Technology at Saint Thomas Heart
The Arctic Front® Cardiac CryoAblation Catheter system, is used to treat paroxysmal atrial fibrillation (PAF), a serious heart rhythm disorder affecting millions of Americans.
The Arctic Front Cardiac CryoAblation Catheter system is a minimally invasive treatment for patients who do not favorably respond to antiarrhythmic medications.
Recently approved by the U.S. Food and Drug Administration, the innovative cryoballoon treatment involves a "percutaneous" or "catheter-based" procedure that efficiently creates lesions around the pulmonary veins, which is the source of erratic electrical signals that cause the irregular heartbeat.
Treatment with this device is safe, with limited procedure-related adverse events (3.1 percent), and a reduction in adverse events caused by atrial fibrillation when compared to drug therapy. Additionally, patients treated with Arctic Front displayed a significant reduction of symptoms, a decrease in the use of drug therapy and substantial improvements in both physical and mental quality-of-life factors.
Saint Thomas Heart is the first in Tennessee to use the Arctic Front® Cardiac CryoAblation Catheter system.
Patients interested in learning more about the procedure may contact Saint Thomas Heart at Saint Thomas West Hospital at 615.269.4545 or Saint Thomas Heart at Saint Thomas Midtown Hospital at 615.329.5144.